Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News


Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Research and Markets: Next Generation Sequencing (NGS) Report 2013: How are NGS Technologies Revolutionizing the Way we Think About Healthcare?

10/10/2013 | 10:30am US/Eastern

Research and Markets (http://www.researchandmarkets.com/research/ddm37b/next_generation) has announced the addition of the "Next Generation Sequencing Report 2013" report to their offering.

The Next Generation Sequencing market is poised to reach $4.4B in 2018!

How are NGS Technologies Revolutionizing the Way we Think About Healthcare?

NGS technologies drive the way toward personalized medicine

Our analysis provides 2013-2018 market data, along with player market shares at both equipment and consumable levels. Moreover, positioning strategy of each supplier has been analyzed in the document.

Discover the NGS market's complex organization, splitted in four segments

The market segmentation is a tool used to provide a vision of the market. Based on technical and economic criteria, fours segments have been identified: research, forensics, diagnostics and consumer.

Until recently, uses of Next Generation Sequencing tools were limited to research (human whole genome, exome, small genome, targeted, transcriptome, RNA profiling, chIP-Seq, metagenomics).

Nowadays, NGS technologies have found applications mainly in two fields: clinical diagnostics and forensics.

Our investigation describes both current and future applications.

Next Generation Sequencing technologies overview

  • In April 2003, human genome project was declared complete. This first human genome sequencing took 13 years, mobilized 20000 researchers and cost $3B!
  • Since the early 2000s, sequencing technologies have come a long way from Sanger sequencing (also called 1st generation sequencing) used for the human genome project to the Next Generation Sequencing technologies available today.
  • By sequencing a large number of DNA molecules in parallel after PCR amplification, technology developers have been able to sharply increase machine throughput by a factor of 10, along with a steep price reduction.
  • The launch of a new detection method based on electrochemical detections was also a huge step forward for the sequencing world.
  • Today, based on these new technologies, we can sequence the whole human genome in less than three hours with one laboratory technician and a total cost around $1000.
  • Technologies under development are poised to extend the boundaries with a targeted sequencing cost of $100.
  • All technologies currently in use and those under development are presented in our report. Benchmarking is also presented for eight different sequencing applications.

New opportunities arise for cartridge makers

  • The wide adoption of NGS technology has changed the way NGS suppliers are generating revenue. A shift occurred in the sales mix, moving from instruments to consumables which have a higher gross margin than instruments.
  • This leads to an increase in revenue based on consumable sales.
  • The number of NGS Platforms used worldwide will exploded in the next several years and the run time will continue to decrease. Therefore, the market of NGS consumables will follow.

Report's key features

- 2013-2018 Next Generation Sequencing equipment market

- 2013-2018 Next Generation Sequencing consumable market

- Market segmentation which highlights current and future applications

- Overview of sequencing technologies and cartridges associated

- Detailed supply chain and business model analysis highlighting the major changes expected over next few years

- Company profiles of the main players

Report objectives

- Provide an overview of global NGS market both at equipment and consumable levels.

- Present main players and technologies involved

- Analyze both technical and market trends

- Focus on microfluidic consumable cartridges used for genome testing

- Supply Chain analysis

Key Topics Covered:

1. Executive summary

2. Introduction

3. Market data

4. Market segmentation

5. Next Generation Sequencing technologies overview

6. Value chain and supply chain

7. Market trends and challenges

8. Company profiles

Companies Mentioned

- 23andme

- Affymetrix

- Azco Biotech Inc

- Baseclear

- Base 4

- BGI-Shenzhen

- Completegenomics

- DNAvision

- Genia Technologies

- Genapsys

- GnuBIO

- Hitachi

- Illumina

- LaserGen

- NabSys

- Noblegen Biosciences

- Oxford Nanopore Technologies

- Pacific Biosciences

- Qiagen

- Roche 454

- Stratos Genomics Inc.

- Thermo Fisher Scientific


For more information visit http://www.researchandmarkets.com/research/ddm37b/next_generation

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

© Business Wire 2013
React to this article
Latest news
Date Title
09:19p FEDEX : truck crash, mudslide snarl traffic on Inland freeways
09:19p STANBIC IBTC BANK : deploys digital assets for national devt
09:18p SUN TZU : How to win the war against insurgents
09:17p Half of Westfield's Village restaurants are now open, and most will serve alcohol
09:14p MINISTRY OF TRADE AND INDUSTRY OF REPUBLIC OF : Trans-Pacific Partnership Negotiations Conclude Successfully
09:14p FAR EAST CONSORTIUM : Joint announcement cessation of trading in the shares and suspension of trading in the bonds of dorsett hospitality international limited
09:14p RNI NL : to Drill New Bryah Basin Copper-Gold Targets
09:12p Australia would have liked more sugar in TPP but happy with deal
09:11p Pacific trade deal adds to U.S. price quandary for biotech drugs
09:11p In Pacific trade deal, Australia gets bigger U.S. sugar allocation
Latest news
Hot News 
CLOUDBUY : Appointment of NOMAD and Broker and Restoration to Trading on AIM
MAX PETROLEUM : Shares Cancelled From AIM Amid Financial Uncertainty (ALLISS)
UBS : Start of renovation of UBS's head office and opening of a new, temporary branch
CONTRAVIR PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-K)
Most Read News
07:24p UNIVERSITY OF ADELAIDE : Tequila plant shows promise for biofuel
07:18p British Airways' last flight out of Uganda
07:22p QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch
06:27p Allocadia's Twin Co-Founders Named to Forty Under 40 List by BIV
Most recommended articles
09:12p Australia would have liked more sugar in TPP but happy with deal
09:11p In Pacific trade deal, Australia gets bigger U.S. sugar allocation
09:11p Pacific trade deal adds to U.S. price quandary for biotech drugs
08:55pDJFuel Prices Fall, but FedEx and UPS Boost Surcharges
08:55pDJPricewaterhouseCoopers Posts 4.1% Rise in Global Revenue